Raymond Hakim
Last active: 6/9/2014

  1. Change in vascular access and hospitalization risk in long-term hemodialysis patients. Lacson E, Wang W, Lazarus JM, Hakim RM (2010) Clin J Am Soc Nephrol 5(11): 1996-2003
    › Primary publication · 20884778 (PubMed) · PMC3001775 (PubMed Central)
  2. A comparison of SF-36 and SF-12 composite scores and subsequent hospitalization and mortality risks in long-term dialysis patients. Lacson E, Xu J, Lin SF, Dean SG, Lazarus JM, Hakim RM (2010) Clin J Am Soc Nephrol 5(2): 252-60
    › Primary publication · 20019120 (PubMed) · PMC2827595 (PubMed Central)
  3. Why is the mortality of dialysis patients in the United States much higher than the rest of the world? Foley RN, Hakim RM (2009) J Am Soc Nephrol 20(7): 1432-5
    › Primary publication · 19443632 (PubMed)
  4. Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. Chan KE, Lazarus JM, Thadhani R, Hakim RM (2009) J Am Soc Nephrol 20(10): 2223-33
    › Primary publication · 19713308 (PubMed) · PMC2754104 (PubMed Central)
  5. The "right" of passage: surviving the first year of dialysis. Wingard RL, Chan KE, Lazarus JM, Hakim RM (2009) Clin J Am Soc Nephrol : S114-20
    › Primary publication · 19995993 (PubMed)
  6. Patient dialysis knowledge is associated with permanent arteriovenous access use in chronic hemodialysis. Cavanaugh KL, Wingard RL, Hakim RM, Elasy TA, Ikizler TA (2009) Clin J Am Soc Nephrol 4(5): 950-6
    › Primary publication · 19389825 (PubMed) · PMC2676183 (PubMed Central)
  7. Oral protein supplementation alone improves anabolism in a dose-dependent manner in chronic hemodialysis patients. Sundell MB, Cavanaugh KL, Wu P, Shintani A, Hakim RM, Ikizler TA (2009) J Ren Nutr 19(5): 412-21
    › Primary publication · 19500999 (PubMed) · PMC2758490 (PubMed Central)
  8. International Quotidian Dialysis Registry: annual report 2009. Nesrallah GE, Suri RS, Moist LM, Cuerden M, Groeneweg KE, Hakim R, Ofsthun NJ, McDonald SP, Hawley C, Caskey FJ, Couchoud C, Awaraji C, Lindsay RM (2009) Hemodial Int 13(3): 240-9
    › Primary publication · 19703054 (PubMed)
  9. Impact of elevated C-reactive protein levels on erythropoiesis- stimulating agent (ESA) dose and responsiveness in hemodialysis patients. Bradbury BD, Critchlow CW, Weir MR, Stewart R, Krishnan M, Hakim RH (2009) Nephrol Dial Transplant 24(3): 919-25
    › Primary publication · 18840893 (PubMed)
  10. Hemodialysis facility-based quality-of-care indicators and facility-specific patient outcomes. Lacson E, Wang W, Lazarus JM, Hakim RM (2009) Am J Kidney Dis 54(3): 490-7
    › Primary publication · 19406544 (PubMed)